Photoredox Catalysis: 1,4-Conjugate Addition of


Journal

Organic letters
ISSN: 1523-7052
Titre abrégé: Org Lett
Pays: United States
ID NLM: 100890393

Informations de publication

Date de publication:
01 05 2020
Historique:
pubmed: 21 4 2020
medline: 2 6 2022
entrez: 21 4 2020
Statut: ppublish

Résumé

In this report, we describe a new photoredox catalyzed 1,4-conjugate addition of

Identifiants

pubmed: 32311269
doi: 10.1021/acs.orglett.0c00873
doi:

Substances chimiques

Acetates 0
Alkenes 0
methyl radical 2229-07-4
Methane OP0UW79H66

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3418-3422

Auteurs

Lakshmaiah Gingipalli (L)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Jeffrey Boerth (J)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

David Emmons (D)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Tyler Grebe (T)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Holia Hatoum-Mokdad (H)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Bo Peng (B)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Li Sha (L)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Sharon Tentarelli (S)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Haixia Wang (H)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Ye Wu (Y)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

XiaoLan Zheng (X)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Scott Edmondson (S)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Ariamala Gopalsamy (A)

Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.

Articles similaires

Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Osteosarcoma Animals Glutathione Oxidation-Reduction Mice
Animals Rumen Methane Fermentation Cannabis

Classifications MeSH